SOFTCARE

2698
27.0400.45% ( +0.120 )
Delay Closed: Nov 16, 16:08:11

Overview

SOFTCARE (2698)

Softcare Limited operates as a hygiene product corporation principally engaged in the development, manufacturing, and sales of baby and feminine hygiene product...

Open
26.940
High
27.420
Low
26.720
Prev. Close
26.920
Volume
870.95K
Turnover
23.62M
Avg Price
27.120
Bid/Ask Ratio
85.19%
Amplitude
2.60%
52wk High
35.273
Volume Ratio
0.27
Turnover Ratio
0.14%
52wk Low
23.233
HK Mkt Cap
16.79B
Market CapHKD
16.79B
P/ETTM
14.76
P/EDynamic
14.12
P/EStatic
--
EPSTTM
1.83
EPSDynamic
1.92
EPSStatic
--
BVPS
8.36
P/B
3.23
HK Shares
620.81M
Dividend YieldTTM
4.89%
DividendTTM
1.323
Shares
620.81M
Min lot size
200
Currency
HKD

SOFTCARE Analyst Rating

View more

Forecast & Rating

Oct 27, 2026
Price forecast
HK$41.6554.03%
Forecast & RatingStrong buy
9analysts
  • Strong buy88.89%
  • Buy11.11%
  • Hold0.00%
  • Sell0.00%
  • Strong sell0.00%

Daily Events

  1. Nov, 10

    Softcare rose 3.27% to HK$28.40 from HK$27.50, reversing an early dip to HK$27.58 and rallying to HK$28.96 in the afternoon, as falling oil prices eased input costs and share gains proceeded as expected, on HK$48.19 million turnover and a thin 0.27% turnover rate. That operating momentum contrasts with the price: Q2 2026 revenue rose 30.56% year on year to HK$1.305 billion, net profit 45.86% to HK$297.3 million at a 22.79% margin, EPS 0.4784 up 20.68% and ROE 22.90%, yet the stock is still 22.83% below its HK$36.80 52-week high, down 9.38% year to date and only just above the HK$28.43 MA60 and HK$25.94 MA20. CLSA keeps a HK$41 target, with consensus nearly 50% above spot, and the company has proposed a restricted stock unit plan. Though the interim report has yet to be fully digested and the shares remain capped near MA60 after a more than 20% retreat from the high.

  2. Nov, 6

    After a 6%-plus gain the prior session on expectations that lower oil prices would ease input costs, Softcare reversed intraday: it tagged HK$29.20 at 09:52, slid to HK$27.56 at 15:29 and closed at HK$27.80, down 4.2% from the prior close of HK$29.02 on HK$47.2 million turnover. The pullback sits against strong fundamentals, with Q2 2026 revenue of HK$1.305 billion up 30.56% year on year, net profit of HK$297 million up 45.86%, net margin at 22.79% and EPS of HK$0.4784 up 20.68%, putting the shares on 15.17x PE. Price positioning remains mid-range: down 11.3% year to date, 24.46% below the 52-week high of HK$36.80 and 16.51% above the June low of HK$23.86, holding above the MA20 of HK$25.75 but below the MA60 of HK$28.66, while CLSA maintains its HK$41 target and Outperform rating. Though the CEO's earlier sale of 2.162 million shares at HK$28.7 keeps near-term supply in focus.

  3. Nov, 5

    Softcare rose 5.83% to HK$29.02 as falling oil prices eased the cost side and market-share gains proceeded in line with expectations; the stock spiked to HK$29.80 at 10:49 in the morning session, slipped to HK$28.48 in the afternoon and settled near HK$29.02 on HK$117.6 million turnover. Fundamentals and price still diverge: Q2 2026 revenue grew 30.56% year on year to HK$1.305 billion and net profit 45.86% to HK$297.3 million, a 22.79% net margin with 22.9% ROE, yet the shares are down 7.4% year to date, 21.14% below the 52-week high of HK$36.80 and only just above the MA60 of HK$28.78 and MA20 of HK$25.66. CLSA keeps a HK$41 target price as an external valuation reference, while CEO Luo Jichao's earlier sale of 2.162 million shares at HK$28.7 remains a counterweight.

  4. Nov, 4

    Softcare (2698.HK) staged a low-open, single-direction advance, closing at HK$27.42 for a 7.87% gain on the prior close of HK$25.42, as buyers concentrated in the afternoon after CLSA reiterated its HK$41 target; the session low of HK$25.42 printed at 09:35 BJ and the high of HK$27.54 at 15:56, with the close near the top of the range. Fundamentals contrast with the price position: Q2 2026 revenue of HK$1.305bn rose 30.56% yoy and net profit of HK$297.3m rose 45.86%, a 22.79% net margin at 14.97x PE and 3.28x PB on a HK$17.0bn market cap with a thin 0.40% turnover rate, yet the stock is still down 12.51% YTD, 25.49% below its 52-week high of HK$36.80 and under the MA60 of HK$28.88, holding only above the MA20 of HK$25.49. Though CEO Luo Jichao earlier sold 2.162 million shares at HK$28.7, supply near that level may still need absorbing.

  5. Nov, 3

    Softcare opened at HK$25.06, spiked 7.1% to HK$26.84 in the first minutes of the morning session, then gave back the entire gain to HK$24.84 by 10:45 before recovering to HK$25.42, a 1.44% close, matching reports that the stock climbed 7% in Hong Kong trading and pointing to concentrated selling near HK$26.8. The pullback sits against strong interim numbers: Q2 revenue of HK$1.305bn rose 30.56% yoy, net profit of HK$297.3m rose 45.86%, net margin reached 22.79% and EPS of HK$0.4784 rose 20.68%, while CLSA kept a HK$41 target. Price positioning still lags that operating trend: at HK$25.42 the shares are below the 60-day MA of HK$29.01, down 18.89% YTD, 30.92% below the 52-week high of HK$36.8 and only 6.54% above the 52-week low of HK$23.86, oscillating around the 20-day MA of HK$25.41; though CEO Luo Jichao's earlier sale of 2.162m shares at HK$28.7 remains overhead supply.

News